Institutional Analysis of Non-metastatic Pancreatic Adenocarcinoma Outcomes from 2011-2016

Overview

About this study

The purpose of this study is to evaluate survival of patients with resectable, borderline resectable pancreatic cancer (BRPC) and locally advanced pancreatic cancer (LAPC) separately and as a group.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 18 years or older.
  • Stage 1, 2 or 3 pancreatic adenocarcinoma.
  • Patients who presented at Mayo Clinic, Rochester between 2011-2016.

Exclusion Criteria:

  • Non-pancreatic adenocarcinoma.
  • Metastatic pancreatic adenocarcinoma.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Amit Mahipal

Closed for enrollment

Contact information:

Amit Mahipal

(507) 293-0487

Mahipal.Amit@mayo.edu

More information

Publications

Publications are currently not available